Introduction
============

Behavioral studies have demonstrated that the gamma-aminobutyric acid (GABA)ergic system in central nucleus of the amygdala (CeA) is linked to the reinforcing properties of ethanol (Koob, [@B18], [@B19], [@B20]; Roberto et al., [@B30]). Thus, microinjection of GABA~A~ receptor antagonists into the rat CeA significantly reduces ethanol self-administration (Hyytia and Koob, [@B16]; Roberts et al., [@B33]) in rodents. Further, corticotropin releasing factor (CRF) and its receptors (CRF1 and CRF2) are also linked to alcohol dependence and anxiety-like behaviors in rodents (Heilig and Koob, [@B14]; Lowery and Thiele, [@B21]; Roberto et al., [@B30]). CRF1 may also contribute to alcohol abuse in humans, as evidenced by the association of CRF1 gene variants with specific drinking patterns in humans (Treutlein et al., [@B37]). However, the molecular mechanisms coupling CRF1, responses to alcohol, and negative emotional state related to ethanol have yet to be determined.

Our previous studies of the CeA demonstrated that acute ethanol application increases IPSC (inhibitory postsynaptic current) amplitudes via increased presynaptic GABA release in rat (Roberto et al., [@B31]) and mouse (Nie et al., [@B25]). Like ethanol, CRF also augments IPSCs in rat (Roberto et al., [@B30]) and mouse (Nie et al., [@B25], [@B26]; Bajo et al., [@B4]) CeA. The ethanol- and CRF-induced increase in GABAergic transmission is mediated by CRF1 receptor activation, but the intracellular signaling mechanisms involved in this alteration in GABA transmission are still unknown. The CRF1 receptor is a G-protein-coupled receptor (GPCR) that is predominantly linked to the activation of adenylyl cyclase (AC), and also other second messenger systems such as inositol trisphosphate and protein kinase C (PKC; Grammatopoulos et al., [@B11]; Blank et al., [@B6]). AC produces the second messenger cyclic AMP, which can bind to the protein kinase A (PKA) regulatory subunit (Hanoune and Defer, [@B12]). There is evidence for PKA acting at neurotransmitter release machinery to regulate synaptic activity (Trudeau et al., [@B38]; Chheda et al., [@B8]; Seino and Shibasaki, [@B35]). It has been suggested that the type 7 isoform of adenylyl cyclase (AC7) might activate the cAMP-dependent signaling pathway downstream of CRF1 (Mons et al., [@B22]). Antoni et al. ([@B3]) demonstrated a coupling of CRF1 to AC9 and AC7. A switch in coupling from AC9 to AC7 results in a more robust cAMP signal when CRF binds to CRF1 (Antoni, [@B2]; Antoni et al., [@B3]). It should be emphasized that AC7 is localized both postsynaptically (striatum, hippocampus) and presynaptically (nucleus accumbens, amygdala; Mons et al., [@B22],[@B23]) and is anatomically positioned to receive signals from GPCRs on both dendrites and axon terminals. AC7 is also a target of ethanol in the brain. The activity of this enzyme is enhanced by ethanol, such that moderately intoxicating concentrations of ethanol significantly potentiate AC7-mediated activation of the cAMP signaling cascade (Mons et al., [@B23]). The physiological consequences of this AC activation have been linked to the release of ACTH from the pituitary (Antoni et al., [@B3]; Pronko et al., [@B28]) and predisposition to depression in women (Hines et al., [@B15]); furthermore, recent studies indicate that acute ethanol exposure can increase neurotransmitter release via activation of AC (Kelm et al., [@B17]), providing another clue into the possible role of AC7 in brain.

Based on prior results (Pronko et al., [@B28]; Roberto et al., [@B30]), we investigated a physiological role for the AC7 signaling pathway in the ethanol and CRF effects on CeA GABAergic transmission by comparing HET (one copy of the ADCY7 gene disrupted) and wild-type (WT) mice. We previously noted that disruption of both copies of ADCY7 in mice results in fetal death on day 11 of gestation (Hines et al., [@B15]). Our current studies showed no significant differences in the mean baseline amplitude of evoked GABA~A~ receptor-mediated inhibitory postsynaptic potentials (GABA~A~-IPSPs) in CeA of HET compared to WT mice. However, in CeA neurons of HET mice, the previously characterized ethanol-induced increase of GABA~A~-IPSPs was abolished. In addition, in CeA neurons from HET mice, the CRF-induced augmentation of IPSPs was also significantly decreased compared to those from WT mice. Thus, our data identify the involvement of the AC7 signaling pathway in both ethanol and CRF sensitivity of GABAergic synapses in CeA.

Materials and Methods
=====================

Electrophysiological studies
----------------------------

### Mouse breeding and care

We studied 14 male adenylyl cyclase type 7 heterozygous mice in which once copy of the ADCY7 gene was disrupted (HET), and their respective WT counterparts (WT; *n* = 14) generated by Hines et al. ([@B15]). We conducted all mouse breeding and care procedures in accordance with the Institutional Animal Care and Use Committee (IACUC) of the University of Colorado at Denver and Health Science Center and The Scripps Research Institute IACUC policies.

### Slice preparation

All electrophysiological experiments were also performed in accordance with The Scripps Research Institute IACUC and NIH guidelines on the care and use of laboratory animals. We prepared CeA slices as previously described (Roberto et al., [@B31], [@B32]; Bajo et al., [@B4]), from male HET mice and their respective WT counterparts (4--5 months old at the time of experimentation) that were anesthetized with halothane (3%) and decapitated. We cut 400 μm thick transverse slices on a Vibratome Series 3000 (Technical Products International, St. Louis, MO, USA), incubated them in an interface configuration for about 30 min, and then completely submerged and continuously superfused (flow rate of 2--4 ml/min) them with warm (31°C), gassed ACSF of the following composition in mM: NaCl, 130; KCl, 3.5; NaH~2~PO~4~, 1.25; MgSO~4~·7H2O, 1.5; CaCl~2~, 2.0; NaHCO~3~, 24; glucose, 10. Drugs were added to the ACSF from stock solutions to obtain known concentrations in the superfusate.

### Electrophysiology

We recorded from neurons principally in the medial subdivision of the CeA with sharp micropipettes filled with 3 M KCl (impedance 60--90 MΩ) using current-clamp mode. We held most neurons near their resting membrane potential (RMP). We evoked pharmacologically isolated GABA~A~-IPSPs by stimulating locally within the CeA through a bipolar stimulating electrode while superfusing the slices with the glutamate receptor blockers 6,7-dinitroquinoxaline-2,3-dione (DNQX; 20 μM) and DL-2-amino-5-phosphonovalerate (DL-APV; 30 μM), and the GABA~B~ receptor antagonist (CGP 55845A; 1 μM). We often superfused 30 μM bicuculline or 50 μM picrotoxin at the end of the experiment to confirm the GABA~A~ nature of the IPSPs. Data were acquired with an Axoclamp-2A preamplifier (Axon Instruments, Foster City, CA, USA) and stored for later analysis using pClamp software (Axon Instruments, Foster City, CA, USA). To determine the experimental IPSP response parameters for each cell, we performed an input--output protocol consisting of a range of five current stimulations (typically between 50 and 250 mA; 0.125 Hz), starting at the threshold current required to elicit an IPSP up to the strength required to elicit the maximum amplitude. The range of stimulation intensities was very comparable between the two groups. The I/O method helps minimize inter-slice variability and, when averaged over multiple cells or slices, reproducibly reveals significant changes in synaptic excitability. The half-maximal (half-max) stimulus strength was maintained throughout the entire duration of the experiment. We normalized the three middle (omitting threshold and maximal) stimulus intensities of five equal steps as 1--3X. Stability of IPSPs was established by stimulating for at least 15 min prior to beginning experiments. We quantified the synaptic responses by averaging two consecutive responses evoked by a half-max intensity (30 s apart, i.e., 1 data point/min) and calculating the IPSP amplitude with Clampfit software (Axon Instruments). We also applied hyperpolarizing and depolarizing current steps (200 pA increments, 750 ms duration) to generate voltage--current (V--I) curves.

To estimate changes in presynaptic effects in each neuron, we examined paired-pulse facilitation (PPF), a phenomenon whereby a secondary evoked synaptic response is increased by a preceding primary stimulation of equal intensity. In our studies, we used 50 ms inter-stimulus intervals. We calculated the paired-pulse ratio as the second IPSP amplitude over that of the first IPSP. All measures were taken before ethanol or CRF superfusion (control), during their superfusion (5--10 min), and following washout (20--30 min). To avoid tachyphylaxis, we superfused ethanol and CRF only once onto a single cell. We express all values as mean ± SEM, analyzed them with a between-subjects ANOVA or within-subject ANOVA with repeated measures and, when appropriate, with the Bonferroni *post hoc* test, with *P* \< 0.05 considered statistically significant. We also used a Student\'s paired or unpaired *t*-test for individual means comparisons.

### Drugs

CGP 55845A was a gift from Novartis Pharma. We purchased DL-AP5, DNQX, picrotoxin, and bicuculline from Sigma (St. Louis, MO, USA), CRF from Chempacific Corp. (Baltimore, MD, USA) and ethanol from Remet (La Mirada, CA, USA).

Results
=======

Basal GABAergic transmission in CeA neurons is comparable between HET and WT mice
---------------------------------------------------------------------------------

We recorded from 78 CeA neurons from male HET and their respective (WT) littermate mice. The mean RMP was −77 ± 1.5 mV and mean input resistance was 106 ± 4 MΩ. The two groups did not show significant differences in these properties. In addition, there were no significant differences in the voltage--current relationship between HET and WT mice (not shown). We evoked pharmacologically isolated GABA~A~-IPSPs by stimulating locally within the CeA. Interestingly, baseline IPSP input--output curves generated by equivalent stimulus intensities were similar in CeA neurons from HET mice and in those from WT littermates (Figure [1](#F1){ref-type="fig"}A). We examined PPF of the IPSPs at 50 ms inter-stimulus intervals and did not find any difference in the basal PPF ratio of IPSPs between the two groups (Figure [1](#F1){ref-type="fig"}B).

![**There is no significant difference in basal GABAergic transmission in the CeA between WT and HET mice**. **(A)** Basal input/output curves of mean GABAA-IPSP amplitudes in the CeA were not altered in HET compared to WT mice (WT: *n* = 21 and HET: *n* = 22). **(B)** Paired-pulse facilitation protocol showed no differences in P2/P1 ratio between WT and HET mice (WT: *n* = 18 and HET: *n* = 22). The top panels in **(A)** and **(B)** show representative recordings from individual CeA neurons. The values are presented as mean IPSP amplitudes ± SEM. Significance was calculated by Student\'s *t*-test and set at \**P* \< 0.05.](fnins-04-00207-g001){#F1}

Ethanol enhancement of GABAergic transmission is absent in CeA neurons of HET mice
----------------------------------------------------------------------------------

Previously we found that ethanol dose-dependently increased GABAergic transmission in CeA slices by increasing presynaptic vesicular GABA release (Roberto et al., [@B31]). In the present study, we investigated whether AC7 plays a role in ethanol-stimulated GABA release. In CeA slices from WT mice, 10 min superfusion of 44 mM ethanol significantly (*P* \< 0.01) increased the mean amplitude of evoked IPSPs by 39 ± 3% at each stimulus strength tested (Figure [2](#F2){ref-type="fig"}A; *n* = 13). To test whether the site of ethanol action was pre or postsynaptic, we assessed PPF, a measure inversely related to neurotransmitter release (Andreasen and Hablitz, [@B1]; Bonci and Williams, [@B7]; Roberto et al., [@B31]). Ethanol significantly (*P* \< 0.01) decreased the PPF of evoked IPSPs by 22 ± 5% in 10 of 11 the CeA neurons from WT mice (Figure [2](#F2){ref-type="fig"}C), suggesting that ethanol increases GABA release. In HET mice with diminished brain AC7 activity, the ethanol-induced augmentation of evoked IPSP amplitudes was completely absent (103 ± 6% of control, *n* = 15, *P* \> 0.05; Figure [2](#F2){ref-type="fig"}B), as was the ethanol-induced reduction in PPF of IPSPs (100 ± 5% of control, *n* = 10, *P* \> 0.05; Figure [2](#F2){ref-type="fig"}D). Ethanol had no significant effects on the membrane properties (V--I curves, RMPs, and input resistance) in either HET or WT mice (data not shown). These data suggest that AC7 plays a critical role in the effects of ethanol on GABAergic transmission in the CeA.

![**The ethanol effects on GABAergic transmission in the CeA are abolished in HET mice**. **(A)** Superfusion of 44 mM ethanol increased IPSP amplitudes, with recovery on washout in CeA neurons of WT naïve (*n* = 13) but not of AC7 HET mice \[*n* = 15; **(B)**\]. Each point represents the mean ± SEM. Percent increase in IPSP amplitude. Top panel: representative recordings showing effect of ethanol on GABAA-IPSPs in the CeA neurons of WT and HET mice, respectively. **(C)** Pooled data of PPF against control (at 50 ms inter-stimulus interval). Ethanol significantly decreased PPF in CeA slices from WT (*n* = 10) but had no effect in HET (*n* = 10) mice **(D)**. PPF is inversely related to transmitter release, suggesting that acute ethanol increases release of GABA in WT. Top panels of **(C)** and **(D)**: representative recordings showing effect of ethanol on PPF in CeA neurons of WT and HET mice, respectively. Statistical significance of ethanol and CRF effects calculated by Student\'s *t*-test and set at \**P* \< 0.05 and \*\**P* \< 0.01.](fnins-04-00207-g002){#F2}

CRF enhancement of GABAergic transmission is reduced in CeA neurons of HET mice
-------------------------------------------------------------------------------

We previously reported that CRF, via activation of CRF1s, presynaptically augments GABAergic transmission in CeA slices from C57BL6/J mice (Nie et al., [@B25], [@B26]; Bajo et al., [@B4]). Recent data suggest that CRF1 activation increases the enzymatic activity of AC7 (Antoni et al., [@B3]; Pronko et al., [@B28]). Therefore, we explored the possible role of AC7 in CRF-dependent stimulation of GABA release in the CeA. In accord with our previous studies (Nie et al., [@B25], [@B26]; Bajo et al., [@B4]), superfusion of 200 nM CRF for 10 min significantly (*P* \< 0.01) increased the mean amplitude of evoked IPSPs of WT CeA by 38 ± 3% (Figure [3](#F3){ref-type="fig"}A; *n* = 9). The CRF-induced increase in the amplitudes of WT IPSPs was associated with a significant (*P* \< 0.05) decrease in PPF by 20 ± 6% in eight of nine cells (Figure [3](#F3){ref-type="fig"}C), suggesting that CRF acts presynaptically to increase GABA release in CeA from WT mice. Although CRF significantly (*P* \< 0.05) increased IPSP amplitude by 13 ± 5%, in HET neurons, this CRF effect represented a significant reduction (by 65%, *P* \< 0.01) compared to the CRF effects in WT mice (Figure [3](#F3){ref-type="fig"}B; *n* = 13). Contrary to the effects seen in WT mice, CRF did not significantly (*P* \> 0.05) alter the PPF ratio of IPSPs in HET mice (95 ± 6% of control, *n* = 11; Figure [3](#F3){ref-type="fig"}D). We did not observe any significant changes in the membrane properties of the CeA neurons induced by CRF in HET or WT mice (data not shown). Thus, our data suggest that both ethanol and CRF act mainly via presynaptic mechanisms. Because we are measuring only evoked (macroscopic) IPSPs of relatively short duration, and not tonic GABA release, changes in conductance and potential could be detected only during the IPSP itself, during either the baseline or treatment conditions.

![**The presynaptic effect of CRF on GABAergic transmission in the CeA is reduced in HET mice**. **(A)** Superfusion of 200 nM CRF significantly increased IPSP amplitudes (38 ± 3%) in CeA neurons of WT naïve (*n* = 9). Although still significant, the CRF-dependent increase in mean IPSP amplitude was significantly (*P* \< 0.01) decreased (to 65%) in HET \[*n* = 13; **(B)**\] compared to WT mice. Upper panels show representative recordings from the CeA neurons of WT and HET mice. **(C)** Superfusion of CRF significantly decreased PPF in CeA slices from WT (*n* = 8) mice, but had no effect on PPF in HET mice \[*n* = 11; **(D)**\]. Top panels show representative recordings from PPF experiments. Data presented as mean ± SEM. Statistical significance calculated by Student\'s *t*-test and set at \**P* \< 0.05 and \*\**P* \< 0.01.](fnins-04-00207-g003){#F3}

Discussion
==========

The CeA plays a critical role in ethanol dependence and anxiety-related behaviors (Roberto et al., [@B30]). In the present study, we validated previous reports from our laboratory that ethanol and CRF increase GABA transmission in CeA neurons via increased presynaptic GABA release (Nie et al., [@B26]; Roberto et al., [@B30]). More importantly, we established that the AC7 pathway is involved in the alteration of GABA release by ethanol and CRF.

The effector molecules that translate signals from receptors (particularly GPCRs) to intracellular signaling pathways (e.g., PKA) are important mediators of ethanol\'s synaptic effects. AC is one of the most ubiquitous signal transduction molecules and its activity in response to activation of GPCRs is altered by acute and chronic ethanol treatment (Tabakoff and Hoffman, [@B36]). Activation of many GPCRs stimulates AC activity to convert ATP to the intracellular second messenger, cAMP. Cyclic AMP, in turn, activates cAMP-dependent PKA, which modulates metabolism, and gene expression. It appears that the magnitude of ethanol\'s actions on AC activity depends on the isoform of AC (Yoshimura and Tabakoff, [@B41], [@B42]). Nine isoforms of the mammalian AC enzyme exist. The type VII isoform of AC (AC7) is distinguished by the fact that it is insensitive to inhibition by Giα, but is stimulated by the βγ subunits (Yoshimura et al., [@B40]). It is sensitive to calcium, and moderate concentrations of ethanol significantly enhance AC7-mediated activation of the cAMP signaling cascade via phosphorylation of AC7 by PKCdelta (Nelson et al., [@B24]), whereas AC 7 is not readily activated by forskolin (Yoshimura and Tabakoff, [@B42]).

Previously we found that the ethanol-induced increase in GABA release in CeA slices is mediated by a mechanism dependent on activation of CRF1s (Nie et al., [@B25], [@B26]; Bajo et al., [@B4]). CRF1 is a potent mediator of stress- and anxiety-related behaviors (Baldwin et al., [@B5]; Rassnick et al., [@B29]; Pich et al., [@B27]) and CRF1s are abundantly expressed in the CeA. CRF1 is a GPCR that is positively linked to the activation of AC and other second messenger systems such as IP3 and PKC (Bajo et al., [@B4]). Several reports suggest that CRF1 couples to both the AC7 and AC9 isoforms (Antoni, [@B2]; Antoni et al., [@B3]). A switch in coupling from AC9 to AC7 results in increased cAMP signaling when CRF1 is activated by CRF. Disruption of CRF1 activation reduces negative affective states of opiate and alcohol withdrawal (Contarino and Papaleo, [@B9]; Gilpin et al., [@B10]), and pharmacological inhibition of CRF1 suppresses stress-mediated alcohol relapse in rats genetically selected for high alcohol preference (Valdez and Koob, [@B39]; Hansson et al., [@B13]). In a recent study (Bajo et al., [@B4]) we demonstrated that PKCε serves two roles in the CeA: (i) to reduce spontaneous baseline GABA release, and (ii) to mediate CRF- and ethanol-stimulated release of GABA. Based on the present data, we believe that the AC/cAMP and PKCε cascades are intimately involved and cross-communicate at some point in their cascades to regulate GABA release, and we speculate that the final target for both pathways is downstream to these cascades. Our previous and current studies suggest that components of the PKC (Bajo et al., [@B4]) and PKA signaling pathways are critical for CRF1-mediated effects in the CeA that could underlie anxiety-like and ethanol-related behaviors.

In the present study, we used male HET mice with diminished AC7 activity (Hines et al., [@B15]) to investigate a role of AC in ethanol- and CRF1-dependent effects on GABAergic transmission in the CeA. We found that despite similar baseline GABA transmission, CeA neurons from male HET mice did not demonstrate the increased GABA transmission (mediated by increased presynaptic GABA release) seen in their WT counterparts after treatment with ethanol or CRF. These data indicate that any imbalance in AC7 activity may have a profound effect on ethanol- and CRF-dependent modulation of the GABA system in the mouse CeA. However, CRF superfusion still elicited a significant but smaller increase of IPSP amplitude in the HET mice, suggesting a different contribution of AC7 pathway to CRF vs ethanol effects. Using Affymetrix gene expression arrays, we previously demonstrated that the only protein coding mRNA which was altered (diminished) in the brain of male HET mice was the ADCY7 product (Hines et al., [@B15]). Although we cannot rule out a possible postsynaptic location of AC7 in the CeA, our current data and the prior data of Mons et al. ([@B23]) suggest that AC7 is localized in presynaptic axon terminals of GABAergic neurons in several brain regions including the cerebellum (Mons et al., [@B23]). Given the sensitivity of AC7 to ethanol and the coupling of AC7 to CRF1, our findings suggest that AC7 responds to ethanol and CRF in the CeA by increasing cAMP signaling and subsequent activation of the PKA cascade. The ethanol- and CRF1-dependent PKA activation, in turn, could modulate downstream effector molecules such as synaptotagmin and voltage sensitive Ca^++^ channels, resulting in an increase in presynaptic vesicular GABA release. However, in the long term, this enhanced signaling may initiate neuroadaptations in AC activity and response to neurotransmitters (Saito et al., [@B34]) that may be critical in inducing alcohol tolerance or dependence.

Based on genome-wide association studies, CRF1 and its downstream signaling effector AC7 have been considered to contribute to alcohol abuse in humans. The variants in the CRHR1 gene encoding the human CRF1 have recently been associated with binge drinking and high alcohol intake in two independent sample populations (Treutlein et al., [@B37]). These data further support and validate findings obtained from animal models of alcohol addiction that dysregulation of the CRF system is underlies the development of alcohol addiction in humans. Interestingly, a recent whole genome association study of a large German population sample demonstrated an association of polymorphisms in ADCY7 and alcoholism in females (S. Desrivieres et al., personal communication).

Overall, our study has added a new player in the complex signaling pathways mediating ethanol and CRF1 effects in the CeA. We identified AC7 as a critical signaling effector molecule involved in the ethanol and CRF1 effects on GABAergic transmission in the CeA. Previous studies indicated that in the CeA, ethanol acts through activation of CRF1 and its signaling pathways. Based on our current study, those signaling pathways include AC7 and subsequently also PKA. Identification of key players of intracellular signaling pathways involved in ethanol effects on neuronal systems is crucial for understanding mechanisms leading to development of ethanol dependence and for finding therapeutic targets for the treatment of alcoholism.
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